Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02127281 · ClinicalTrials.gov registry record · NA

Evaluation of Wound Management With Negative Pressure Dressing Versus Standard Dressing After Revision Arthroplasty.

A NA study of Musculoskeletal Diseases and Joint Diseases, sponsored by The Cleveland Clinic.

Completed
Registry status
NA
Development phase
160
Enrollment target
1
Study location

NCT02127281: Completed NA study of Musculoskeletal Diseases and Joint Diseases, sponsored by The Cleveland Clinic.

NCT02127281 is a NA study of Musculoskeletal Diseases and Joint Diseases that has completed, run by The Cleveland Clinic. The registered enrollment target is 160 participants, below the 541-participant average among 11 other Musculoskeletal Diseases trials with a reported enrollment target (70% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02127281, a NA study of Musculoskeletal Diseases and Joint Diseases, has completed, sponsored by The Cleveland Clinic.

COMPLETED
Registry status
NA
Development phase
160 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine the efficacy of a negative pressure wound therapy (NPWT) system after revision total knee and hip arthroplasty in patients at high risk for infection. It is hypothesized that the use of NPWT system (i.e., Prevena) in high risk patients prevents wound complications and decreases reoperation rates.

Primary Outcome

Any wound complications including but not limited to drainage, blisters, cellulitis, superficial infection, and deep infection.

Interventions

  • DEVICE Prevena

Study Locations (1)

Ohio

  • Cleveland Clinic - Cleveland

Trial Details

FieldValue
Enrollment Target 160 participants
Start Date 2014-05
Est. Completion 2017-06-30
Phase NA
The Cleveland Clinic

688 total trials

What the finished NCT02127281 record still lists

NCT02127281 is an interventional study that assigns participants to a tested intervention. The registered 160 participants enrollment target is mid-sized for trials with a published cap, below the 541-participant average among 11 other Musculoskeletal Diseases trials with a reported enrollment target (70% lower).

The record links to 4 conditions, with Musculoskeletal Diseases appearing as the primary indexed condition, and to 1 intervention - of which Prevena is the first listed.

NCT02127281 reports a single indexed study location in Ohio.

Frequently Asked Questions

What is clinical trial NCT02127281 about?

NCT02127281 is a clinical study titled "Evaluation of Wound Management With Negative Pressure Dressing Versus Standard Dressing After Revision Arthroplasty.". The purpose of this study is to determine the efficacy of a negative pressure wound therapy (NPWT) system after revision total knee and hip arthroplasty in patients at high risk for infection. It is hypothesized that the use of NPWT system (i.e., Prevena) in high risk patients prevents wound complic...

What is the current status of trial NCT02127281?

This trial is currently completed. It is a NA study. The enrollment target is 160 participants. The study started on 2014-05. Estimated completion is 2017-06-30.

What conditions does trial NCT02127281 study?

This clinical trial studies the following conditions: Musculoskeletal Diseases, Joint Diseases, Wound Complications, Prosthesis-related Infections.

What interventions are being tested in trial NCT02127281?

The interventions under investigation include: Prevena (DEVICE).

Who is sponsoring clinical trial NCT02127281?

This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02127281 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Musculoskeletal Diseases

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02127281's enrollment target sits among peer trials

160 4th of 11 higher than 8 of 11 other Musculoskeletal Diseases trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Musculoskeletal Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00501826 · 160 participants · Phase 2

    Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

  • NCT00932139 · 160 participants · NA

    Effect of Electro-Acupuncture on Blood Pressure

  • NCT00992901 · 160 participants · Early Phase 1

    Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass Surgery

  • NCT01515527 · 160 participants · Phase 2

    Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02127281, the US trial registry maintained by the National Library of Medicine. NCT02127281 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.